XML 31 R24.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings per share
6 Months Ended
Jun. 30, 2023
Text block1 [abstract]  
Earnings per share

Note 17. Earnings per share

 

 

 

For the six-month period ended June 30,

 

 

2022

 

 

2023

 

Net income (loss) attributable to shareholders of
   Cellectis ($ in thousands)

 

 

(50,858

)

 

 

(40,715

)

Net income (loss) attributable to shareholders of
   Cellectis ($ in thousands) from discontinued
   operations

 

 

(3,531

)

 

 

(4,984

)

Adjusted weighted average number of outstanding
   shares, used to calculate both basic and diluted
   net result per share

 

 

45,497,127

 

 

 

53,541,010

 

Basic / Diluted net income (loss) per share
   attributable to shareholders of Cellectis

 

 

 

 

 

 

Basic net income (loss) attributable to shareholders
   of Cellectis per share ($ /share)

 

 

(1.12

)

 

 

(0.76

)

Basic earnings from discontinued operations per
   share ($ /share)

 

 

(0.08

)

 

 

(0.09

)

Diluted net income (loss) attributable to
   shareholders of Cellectis per share ($ /share)

 

 

(1.12

)

 

 

(0.76

)

Diluted earnings from discontinued operations
   per share ( $ /share)

 

 

(0.08

)

 

 

(0.09

)

 

When we have adjusted net loss, we use the weighted average number of outstanding shares, basic to compute the diluted adjusted net income (loss) attributable to shareholders of Cellectis ($/share). When we have adjusted net income, we use the weighted average number of outstanding shares, diluted to compute the diluted adjusted net income (loss) attributable to shareholders of Cellectis ($/share).